PD-1/PD-L1 Inhibitors May Improve Survival in NPC - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

PD-1/PD-L1 Inhibitors May Improve Survival in NPC

Meta-analysis suggests survival and response benefits alongside notable toxicity in recurrent or metastatic disease

  • By

  • Andrea Surnit

  • April 22, 2026

  • 2 min

Share

Original Source(s)

PD-1/PD-L1 Inhibitors May Improve Survival in NPC

  • by Andrea Surnit

  • April 22, 2026

Related Content

Editorial: Biomarkers in head and neck cancer: genomic insights and nuclear medicine innovations

Oncogenic viruses and their role in oral cavity and oropharyngeal squamous cell carcinoma: a systematic review

Treatment With the Shaker Head-Lift Exercise in Head and Neck Cancer Patients With Radiation-Induced Dysphagia: 12-Month Results on Swallowing Function From a Randomized, Controlled Trial